SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001768824-19-000008
Filing Date
2019-11-27
Accepted
2019-11-27 13:15:45
Documents
1
Group Members
SHIRA CAPITAL LLCTRADELINK SECURITIES LLCTRIPLETAIL CAPITAL MANAGEMENT LP

Document Format Files

Seq Description Document Type Size
1 AMENDMENT 2 efc19-628_sc13datest.htm SC 13D/A 196305
  Complete submission text file 0001768824-19-000008.txt   197829
Mailing Address 1460 BROADWAY SUITE 15044 NEW YORK NY 10036
Business Address 1460 BROADWAY SUITE 15044 NEW YORK NY 10036 212-776-4381
Ovid Therapeutics Inc. (Subject) CIK: 0001636651 (see all company filings)

IRS No.: 465270895 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-90350 | Film No.: 191255841
SIC: 2834 Pharmaceutical Preparations

Mailing Address 100 NORTH BISCAYNE BLVD MIAMI FL 33132
Business Address 100 NORTH BISCAYNE BLVD MIAMI FL 33132 3122642196
TLS Advisors LLC (Filed by) CIK: 0001768824 (see all company filings)

IRS No.: 205570195
Type: SC 13D/A